Medicare pays doctors to screen women aged 40-74 for breast cancer risk.
S. 5258 — PREFERRED Screening Act · Filed by Bill Cassidy (R-LA) · 1 cosponsor · Introduced Aug 5, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
The bill creates a new way for Medicare to pay doctors. Doctors will do breast cancer risk checks for people aged 40 to 74. Doctors will use gene tests and family history to find risk. They will also look at breast tissue type and habits. Doctors will then make a plan for how often screening should happen. The program will run for 7 years. It will focus on areas where more people die from breast cancer. It will also focus on areas where fewer people get care.
Who it affects
People on Medicare aged 40 to 74 will get risk checks. Doctors and other health workers will get paid to do these checks. People in areas with less care are the main focus.
One thing to notice
The bill pays for gene tests and risk plans. It does not require proof that screening helps people stay well.
From the analysis of the bill text, linked under Primary records below.
Where it stands
1 cosponsor: 1 Republicans.
- Aug 5, 2026 — Introduced · Congress.gov: “Introduced in Senate”
- Aug 5, 2026 — Referred to Senate Committee on Finance · Congress.gov: “Read twice and referred to the Committee on Finance”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
1 groups reported lobbying about this bill. They filed 1 reports from Sep 2026 to Sep 2026.
Those reports show $40,000 in lobbying spending. Each report lists about 15 bills. So that money was not all for this bill.
More groups named this bill than 0% of bills with any report.
Bill Cassidy, who sponsored the bill, received $1,068,854 from PACs for the 2026 election.
- Susan G. Komen — $40,000 in 1 report
Lobbying is legal. These reports show who lobbied about this bill, not what changed.
Words to know
- gene tests — Tests that look at a person's DNA to find disease risk.
- breast tissue type — How much fibrous tissue versus fat is in the breast.
- screening — Tests done to find disease in people who have no signs of illness.
- areas with less care — Places where people have less access to doctors and health care.
- lobbying — Trying to influence lawmakers about a bill. Companies and groups pay people to do this.
- PACs — Groups that collect money and give it to candidates for office.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (15,413 characters) on Aug 12, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 17,910 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Sep 2026 to Sep 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Oct 19, 2026 · page rendered 2026-11-22.
“Medicare pays doctors to screen women aged 40-74 for breast cancer risk.” QuorumCivic. https://share.quorumcivic.app/bill/119/s5258/simple Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.